Prevalence of Adrenal Insufficiency Following Systemic Glucocorticoid Therapy in Infants With Hemangiomas

Abstract

Setting: Hemangioma and vascular malformation center at a tertiary care children's hospital. Patients: Sixteen infants with hemangiomas had an adrenal axis evaluation as soon as possible following the completion of GC therapy. Ten healthy control infants were also evaluated for comparison. Interventions: Prednisolone at a starting dose of 2 to 3 mg/kg/d for 4 weeks, followed by a tapering period. The mean duration of GC treatment was 7.2 months. Main Outcome Measure: Prevalence of adrenal insufficiency in GC-treated subjects as assessed by a combination low-dose/high-dose corticotropin stimulation test. Results: Subjects underwent corticotropin testing at a mean of 13 days after the completion of therapy. Only 1 of the 16 GC-treated infants (6%) had adrenal insufficiency. This subject was tested 1 day after GC treatment was stopped, and results from retesting 3 months later were normal. All control subjects had normal adrenal function. Conclusion: Infants with hemangiomas are at low risk of adrenal insufficiency following the completion of GC therapy, as used in our hemangioma center.

Intralesional Injection of Diprospan is Effective for Infantile Hemangioma

“…7 Since the first report in 2008, 8 oral propranolol treatment for severe hemangioma has shown great advantages 9-11 with a trend of replacing oral corticosteroids. The clinical effect has been confirmed by numerous clinical studies.…”

Alopecia areata

“…In addition, patients who have been treated with adalimumab, infliximab or etanercept for other autoimmune disorders have developed alopecia areata during the course of treatment 168,169 . Finally, small randomized trials of efalizumab (anti-CD11A) 170 and alefacept (anti-CD2) 171 showed no benefit in alopecia areata.…”

Management of infantile hemangiomas: Current trends

“…The authors commented that measuring morning serum cortisol levels, which is less specific than corticotropin stimulation test for assessing the HPA axis suppression, and measuring the cortisol levels while the patient is still on corticosteroid therapy could explain the higher incidence of adrenal insufficiency reported in the earlier studies. [24]…”